MoonLake Immunotherapeutics (MLTX) Treasury Shares (2020 - 2022)

MoonLake Immunotherapeutics' Treasury Shares history runs 1 years deep, the most recent figure standing at $6202.0 for Q4 2021.

• In Q1 2025, Treasury Shares fell 88.91% year-over-year to $246302.0; the TTM figure through Mar 2025 stood at $246302.0 (down 88.91% YoY), while the FY2024 annual figure was $319769.0, down 49.28% from the prior year.
• Treasury Shares for Q1 2025 stood at $246302.0, down from $319769.0 in the prior quarter.
• The five-year high for Treasury Shares was $2.8 million in Q2 2022, with the low at $246302.0 in Q1 2025.
• The 5-year median for Treasury Shares is $2.2 million (2024), against an average of $1.7 million.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares jumped 192.35% in 2023, then slumped 88.91% in 2025.
• MoonLake Immunotherapeutics' Treasury Shares stood at $1.9 million in 2021, then increased by 3.05% to $1.9 million in 2022, then tumbled by 67.54% to $630490.0 in 2023, then slumped by 49.28% to $319769.0 in 2024, then retreated by 22.98% to $246302.0 in 2025.
• Business Quant data shows MLTX's Treasury Shares at $246302.0 in Q1 2025, $319769.0 in Q4 2024, and $2.2 million in Q3 2024.